AGM/EGMJun 1, 2026, 04:01 PM
Spectral AI Stockholders Approve Proposals, Elect Directors
AI Summary
Spectral AI, Inc. announced the results of its 2026 Annual Meeting of Stockholders, where all three proposals were approved. Stockholders elected five directors, ratified Forvis Mazars LLP as the independent auditor, and authorized the issuance of shares to Hudson Bay Master Fund Ltd. The company also provided a business update, highlighting the recent FDA De Novo Classification for its DeepView System for Burn Indication, which enables commercial distribution in the U.S. Spectral AI outlined key operational achievements, including $31.7 million in BARDA funding, and anticipates generating first commercial sales by year-end 2026.
Key Highlights
- Stockholders elected J. Michael DiMaio, Richard Cotton, Martin Mellish, Deepak Sadagopan, and Marion Snyder to the Board of Directors.
- Stockholders ratified the appointment of Forvis Mazars LLP as the independent registered public accounting firm for fiscal year 2026.
- Stockholders approved the authorization for reservation and issuance of common stock for sale to Hudson Bay Master Fund Ltd.
- The DeepView System received FDA De Novo Classification for Burn Indication, allowing commercial distribution in the US.
- Spectral AI was awarded $31.7 million in advanced funding from BARDA to accelerate DeepView System features.
- The company anticipates generating first-ever commercial sales of the DeepView System by year-end 2026 in the US and internationally.
- An Outcome Study for the DeepView System is planned to initiate in Q4 2026, focusing on surgical precision and patient care benefits.
Price Impact
More from MDAI